161 related articles for article (PubMed ID: 18974106)
1. Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice.
Lee C; Dhillon J; Wang MY; Gao Y; Hu K; Park E; Astanehe A; Hung MC; Eirew P; Eaves CJ; Dunn SE
Cancer Res; 2008 Nov; 68(21):8661-6. PubMed ID: 18974106
[TBL] [Abstract][Full Text] [Related]
2. YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cells.
Fujii T; Seki N; Namoto-Matsubayashi R; Takahashi H; Inoue Y; Toh U; Kage M; Shirouzu K
Future Oncol; 2009 Mar; 5(2):153-6. PubMed ID: 19284373
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.
Wu J; Lee C; Yokom D; Jiang H; Cheang MC; Yorida E; Turbin D; Berquin IM; Mertens PR; Iftner T; Gilks CB; Dunn SE
Cancer Res; 2006 May; 66(9):4872-9. PubMed ID: 16651443
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
[TBL] [Abstract][Full Text] [Related]
5. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
Fang P; Hwa V; Rosenfeld RG
Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
8. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
9. Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene.
Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V
Mol Carcinog; 2010 Feb; 49(2):114-20. PubMed ID: 20027636
[TBL] [Abstract][Full Text] [Related]
10. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.
Jing N; Li Y; Xiong W; Sha W; Jing L; Tweardy DJ
Cancer Res; 2004 Sep; 64(18):6603-9. PubMed ID: 15374974
[TBL] [Abstract][Full Text] [Related]
11. [Growth inhibition of breast cancer cells in vitro and in vivo by siRNA targeting signal transducers and activators of transcription 3].
Yang Z; Yan L; Zhang F; Yan QH; Song WQ; Wang FA; Cai JH
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):819-24. PubMed ID: 21223686
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells.
Gao L; Li F; Dong B; Zhang J; Rao Y; Cong Y; Mao B; Chen X
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1223-31. PubMed ID: 20610043
[TBL] [Abstract][Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.
Ling X; Arlinghaus RB
Cancer Res; 2005 Apr; 65(7):2532-6. PubMed ID: 15805244
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
[TBL] [Abstract][Full Text] [Related]
17. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
18. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
[TBL] [Abstract][Full Text] [Related]
19. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
Alvarez JV; Greulich H; Sellers WR; Meyerson M; Frank DA
Cancer Res; 2006 Mar; 66(6):3162-8. PubMed ID: 16540667
[TBL] [Abstract][Full Text] [Related]
20. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]